tradingkey.logo
tradingkey.logo

OraSure Technologies Inc

OSUR
2.410USD
+0.020+0.84%
終値 12/22, 16:00ET15分遅れの株価
174.16M時価総額
損失額直近12ヶ月PER

OraSure Technologies Inc

2.410
+0.020+0.84%

詳細情報 OraSure Technologies Inc 企業名

OraSure Technologies, Inc. transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. The Company improves the access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers. Its products and services include OraQuick ADVANCE Rapid HIV1/2 Antibody Test, OraQuick HIV Self-Test, and Diagnostics Direct Syphilis Health Check.

OraSure Technologies Incの企業情報

企業コードOSUR
会社名OraSure Technologies Inc
上場日Nov 17, 1986
最高経営責任者「CEO」Eglinton Manner (Carrie)
従業員数501
証券種類Ordinary Share
決算期末Nov 17
本社所在地220 E First St
都市BETHLEHEM
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号18015
電話番号15036416115
ウェブサイトhttps://www.orasure.com/
企業コードOSUR
上場日Nov 17, 1986
最高経営責任者「CEO」Eglinton Manner (Carrie)

OraSure Technologies Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Kenneth J. (Ken) Mcgrath
Mr. Kenneth J. (Ken) Mcgrath
Chief Financial Officer
Chief Financial Officer
448.46K
-2.72%
Dr. Nancy J. Gagliano, M.D.
Dr. Nancy J. Gagliano, M.D.
Independent Director
Independent Director
160.25K
+1.33%
Mr. John P. Kenny
Mr. John P. Kenny
Independent Chairman of the Board
Independent Chairman of the Board
153.32K
+4.16%
Mr. Lelio Marmora
Mr. Lelio Marmora
Independent Director
Independent Director
130.76K
+93.09%
Hon Dr. David J. Shulkin, M.D.
Hon Dr. David J. Shulkin, M.D.
Independent Director
Independent Director
126.33K
+109.45%
Ms. Anne Messing
Ms. Anne Messing
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Robert W. Mcmahon
Mr. Robert W. Mcmahon
Independent Director
Independent Director
--
--
Mr. Jason Plagman
Mr. Jason Plagman
Vice President - Investor Relations
Vice President - Investor Relations
--
--
Ms. Carrie Eglinton Manner
Ms. Carrie Eglinton Manner
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Steven K. (Steve) Boyd
Mr. Steven K. (Steve) Boyd
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Kenneth J. (Ken) Mcgrath
Mr. Kenneth J. (Ken) Mcgrath
Chief Financial Officer
Chief Financial Officer
448.46K
-2.72%
Dr. Nancy J. Gagliano, M.D.
Dr. Nancy J. Gagliano, M.D.
Independent Director
Independent Director
160.25K
+1.33%
Mr. John P. Kenny
Mr. John P. Kenny
Independent Chairman of the Board
Independent Chairman of the Board
153.32K
+4.16%
Mr. Lelio Marmora
Mr. Lelio Marmora
Independent Director
Independent Director
130.76K
+93.09%
Hon Dr. David J. Shulkin, M.D.
Hon Dr. David J. Shulkin, M.D.
Independent Director
Independent Director
126.33K
+109.45%
Ms. Anne Messing
Ms. Anne Messing
Chief Commercial Officer
Chief Commercial Officer
--
--

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Net product and services revenues - COVID-19
14.40M
46.09%
Net product and services revenues - HIV
9.86M
31.54%
Net product and service revenues -Molecular Products
4.13M
13.21%
Other revenues - Other non Product revenues
1.40M
4.47%
Net product and services revenues - Risk assessment testing
994.00K
3.18%
他の
474.00K
1.52%
地域別USD
会社名
収益
比率
United States
19.85M
63.54%
Africa (Region)
8.03M
25.69%
Europe
2.12M
6.78%
Other Regions
1.25M
3.99%
事業別
地域別
事業別USD
会社名
収益
比率
Net product and services revenues - COVID-19
14.40M
46.09%
Net product and services revenues - HIV
9.86M
31.54%
Net product and service revenues -Molecular Products
4.13M
13.21%
Other revenues - Other non Product revenues
1.40M
4.47%
Net product and services revenues - Risk assessment testing
994.00K
3.18%
他の
474.00K
1.52%

株主

更新時刻: Sat, Nov 15
更新時刻: Sat, Nov 15
株主統計
種類
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
7.81%
Private Management Group, Inc.
7.55%
Neuberger Berman, LLC
5.86%
The Vanguard Group, Inc.
5.76%
Altai Capital Management, L.P.
5.21%
他の
67.80%
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
7.81%
Private Management Group, Inc.
7.55%
Neuberger Berman, LLC
5.86%
The Vanguard Group, Inc.
5.76%
Altai Capital Management, L.P.
5.21%
他の
67.80%
種類
株主統計
比率
Investment Advisor
36.59%
Investment Advisor/Hedge Fund
27.60%
Hedge Fund
23.49%
Individual Investor
6.13%
Research Firm
2.26%
Pension Fund
0.47%
Bank and Trust
0.29%
Venture Capital
0.11%
Insurance Company
0.04%
他の
3.02%

機関投資家保有株

更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
451
66.91M
93.28%
-15.50M
2025Q2
473
72.08M
98.55%
-16.70M
2025Q1
483
70.23M
93.78%
-12.52M
2024Q4
475
70.81M
94.94%
-10.37M
2024Q3
471
70.30M
94.28%
-10.80M
2024Q2
477
73.05M
98.74%
-8.54M
2024Q1
473
74.45M
97.36%
-5.59M
2023Q4
464
73.29M
99.74%
-5.62M
2023Q3
456
72.50M
98.73%
-4.51M
2023Q2
452
70.73M
96.51%
-2.77M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
BlackRock Institutional Trust Company, N.A.
5.43M
7.43%
-141.00K
-2.53%
Jun 30, 2025
Private Management Group, Inc.
5.46M
7.47%
+1.04M
+23.64%
Jun 30, 2025
Neuberger Berman, LLC
4.16M
5.68%
-124.14K
-2.90%
Jun 30, 2025
The Vanguard Group, Inc.
4.17M
5.7%
-120.08K
-2.80%
Jun 30, 2025
Altai Capital Management, L.P.
3.75M
5.13%
+1.59M
+73.37%
Sep 02, 2025
Dimensional Fund Advisors, L.P.
3.84M
5.25%
+14.96K
+0.39%
Jun 30, 2025
Systematic Financial Management, L.P.
2.23M
3.05%
+581.93K
+35.33%
Jun 30, 2025
Renaissance Technologies LLC
2.28M
3.11%
-294.84K
-11.47%
Jun 30, 2025
Acadian Asset Management LLC
2.19M
3%
-563.24K
-20.44%
Jun 30, 2025
Millennium Management LLC
1.23M
1.69%
+28.80K
+2.39%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Invesco NASDAQ Future Gen 200 ETF
0.44%
iShares US Small Cap Value Factor ETF
0.12%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.05%
iShares Micro-Cap ETF
0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.04%
Avantis US Small Cap Equity ETF
0.02%
WisdomTree US SmallCap Fund
0.02%
ProShares UltraPro Russell2000
0.01%
Proshares Ultra Russell 2000
0.01%
DFA Dimensional US Small Cap Value ETF
0.01%
詳細を見る
Invesco NASDAQ Future Gen 200 ETF
比率0.44%
iShares US Small Cap Value Factor ETF
比率0.12%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
比率0.05%
iShares Micro-Cap ETF
比率0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
比率0.04%
Avantis US Small Cap Equity ETF
比率0.02%
WisdomTree US SmallCap Fund
比率0.02%
ProShares UltraPro Russell2000
比率0.01%
Proshares Ultra Russell 2000
比率0.01%
DFA Dimensional US Small Cap Value ETF
比率0.01%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

OraSure Technologies Incの上位5名の株主は誰ですか?

OraSure Technologies Incの上位5名の株主は以下のとおりです。
BlackRock Institutional Trust Company, N.A.は5.43M株を保有しており、これは全体の7.43%に相当します。
Private Management Group, Inc.は5.46M株を保有しており、これは全体の7.47%に相当します。
Neuberger Berman, LLCは4.16M株を保有しており、これは全体の5.68%に相当します。
The Vanguard Group, Inc.は4.17M株を保有しており、これは全体の5.70%に相当します。
Altai Capital Management, L.P.は3.75M株を保有しており、これは全体の5.13%に相当します。

OraSure Technologies Incの株主タイプ上位3種は何ですか?

OraSure Technologies Incの株主タイプ上位3種は、
BlackRock Institutional Trust Company, N.A.
Private Management Group, Inc.
Neuberger Berman, LLC

OraSure Technologies Inc(OSUR)の株式を保有している機関の数はいくつですか?

2025Q3時点で、OraSure Technologies Incの株式を保有している機関は451社あり、保有株式の総市場価値は約66.91Mで、全体の93.28%を占めています。2025Q2と比較して、機関の持ち株は-5.27%増加しています。

OraSure Technologies Incの最大の収益源は何ですか?

FY2025Q2において、Net product and services revenues - COVID-19部門がOraSure Technologies Incにとって最大の収益を生み出しており、その金額は14.40Mで、全収益の46.09%を占めています。
KeyAI